Annual Gross Profit
$640.00 K
-$13.98 M-95.62%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual gross profit is $640.00 thousand, with the most recent change of -$13.98 million (-95.62%) on December 31, 2023.
- During the last 3 years, AVTX annual gross profit has fallen by -$5.76 million (-90.00%).
- AVTX annual gross profit is now -97.65% below its all-time high of $27.18 million, reached on December 31, 2017.
Performance
AVTX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$963.00 K
+$1.31 M+380.76%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly gross profit is $963.00 thousand, with the most recent change of +$1.31 million (+380.76%) on September 30, 2024.
- Over the past year, AVTX quarterly gross profit has increased by +$1.31 million (+380.76%).
- AVTX quarterly gross profit is now -96.15% below its all-time high of $25.04 million, reached on September 30, 2017.
Performance
AVTX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$1.49 M
+$974.00 K+188.03%
September 30, 2024
Summary
- As of February 8, 2025, AVTX TTM gross profit is $1.49 million, with the most recent change of +$974.00 thousand (+188.03%) on September 30, 2024.
- Over the past year, AVTX TTM gross profit has increased by +$974.00 thousand (+188.03%).
- AVTX TTM gross profit is now -95.56% below its all-time high of $33.62 million, reached on June 30, 2018.
Performance
AVTX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
AVTX Gross Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -95.6% | +380.8% | +188.0% |
3 y3 years | -90.0% | +248.9% | -89.8% |
5 y5 years | -83.0% | -53.5% | -89.8% |
AVTX Gross Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -95.6% | at low | -93.3% | +280.3% | -89.8% | +1103.2% |
5 y | 5-year | -95.6% | at low | -93.3% | +280.3% | -89.8% | +1103.2% |
alltime | all time | -97.7% | -100.0% | -96.2% | +123.0% | -95.6% | +1103.2% |
Avalo Therapeutics Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $963.00 K(-380.8%) | $1.49 M(+188.0%) |
Jun 2024 | - | -$343.00 K(-528.8%) | $518.00 K(-34.9%) |
Mar 2024 | - | $80.00 K(-89.9%) | $796.00 K(+24.4%) |
Dec 2023 | $640.00 K(-95.6%) | $792.00 K(-7300.0%) | $640.00 K(+416.1%) |
Sep 2023 | - | -$11.00 K(-83.1%) | $124.00 K(-99.1%) |
Jun 2023 | - | -$65.00 K(-14.5%) | $14.56 M(+3.3%) |
Mar 2023 | - | -$76.00 K(-127.5%) | $14.09 M(-3.6%) |
Dec 2022 | $14.62 M(+274.1%) | $276.00 K(-98.1%) | $14.62 M(+3.4%) |
Sep 2022 | - | $14.42 M(-2800.6%) | $14.13 M(+8960.9%) |
Jun 2022 | - | -$534.00 K(-217.9%) | $156.00 K(-96.1%) |
Mar 2022 | - | $453.00 K(-321.0%) | $3.96 M(+1.5%) |
Dec 2021 | $3.91 M(-38.9%) | -$205.00 K(-146.4%) | $3.90 M(-29.4%) |
Sep 2021 | - | $442.00 K(-86.5%) | $5.53 M(-9.7%) |
Jun 2021 | - | $3.27 M(+726.3%) | $6.12 M(+49.0%) |
Mar 2021 | - | $396.00 K(-72.1%) | $4.11 M(-35.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $6.40 M(-12.5%) | $1.42 M(+37.1%) | $6.40 M(+16.0%) |
Sep 2020 | - | $1.03 M(-17.9%) | $5.52 M(-15.8%) |
Jun 2020 | - | $1.26 M(-53.1%) | $6.55 M(-19.9%) |
Mar 2020 | - | $2.69 M(+401.9%) | $8.18 M(+11.8%) |
Dec 2019 | $7.32 M(+94.2%) | $535.60 K(-74.1%) | $7.32 M(+181.0%) |
Sep 2019 | - | $2.07 M(-28.4%) | $2.60 M(+73.7%) |
Jun 2019 | - | $2.89 M(+58.4%) | $1.50 M(-24.0%) |
Mar 2019 | - | $1.82 M(-143.7%) | $1.97 M(-47.7%) |
Dec 2018 | $3.77 M(-86.1%) | -$4.18 M(-533.5%) | $3.77 M(-60.5%) |
Sep 2018 | - | $963.50 K(-71.3%) | $9.54 M(-71.6%) |
Jun 2018 | - | $3.36 M(-7.1%) | $33.62 M(+11.1%) |
Mar 2018 | - | $3.62 M(+126.5%) | $30.25 M(+13.6%) |
Dec 2017 | $27.18 M(+2257.1%) | $1.60 M(-93.6%) | $26.64 M(+6.4%) |
Sep 2017 | - | $25.04 M | $25.04 M |
Dec 2016 | $1.15 M(>+9900.0%) | - | - |
Dec 2015 | $0.00 | - | - |
FAQ
- What is Avalo Therapeutics annual gross profit?
- What is the all time high annual gross profit for Avalo Therapeutics?
- What is Avalo Therapeutics annual gross profit year-on-year change?
- What is Avalo Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly gross profit year-on-year change?
- What is Avalo Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Avalo Therapeutics?
- What is Avalo Therapeutics TTM gross profit year-on-year change?
What is Avalo Therapeutics annual gross profit?
The current annual gross profit of AVTX is $640.00 K
What is the all time high annual gross profit for Avalo Therapeutics?
Avalo Therapeutics all-time high annual gross profit is $27.18 M
What is Avalo Therapeutics annual gross profit year-on-year change?
Over the past year, AVTX annual gross profit has changed by -$13.98 M (-95.62%)
What is Avalo Therapeutics quarterly gross profit?
The current quarterly gross profit of AVTX is $963.00 K
What is the all time high quarterly gross profit for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly gross profit is $25.04 M
What is Avalo Therapeutics quarterly gross profit year-on-year change?
Over the past year, AVTX quarterly gross profit has changed by +$1.31 M (+380.76%)
What is Avalo Therapeutics TTM gross profit?
The current TTM gross profit of AVTX is $1.49 M
What is the all time high TTM gross profit for Avalo Therapeutics?
Avalo Therapeutics all-time high TTM gross profit is $33.62 M
What is Avalo Therapeutics TTM gross profit year-on-year change?
Over the past year, AVTX TTM gross profit has changed by +$974.00 K (+188.03%)